Numab Therapeutics Ag
USPTO Trademark & Patent Filings
Trademark applications and grants for Numab Therapeutics Ag. Numab Therapeutics Ag has 1 trademark applications. The latest application filed is for "NUMAB"
- Company Aliases
- Numab Therapeutics AG
- ag therapeutics numab
- Numab Therapeutics AG - Wadenswil CH
- NUMAB THERAPEUTICS AG - Wadenswil CH
- Numab Therapeutics AG - Waedenswil CH
Trademarks Patents
| Patent Application | Date |
|---|---|
| MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETING IL-17A, AND METHODS OF USE THEREOF 20220127350 - 17/427208 Urech; David ; et al. | 2022-04-28 |
| ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF 20210395379 - 17/283128 Gunde; Tea ; et al. | 2021-12-23 |
| ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF 20200332015 - 16/754097 GUNDE; Tea ; et al. | 2020-10-22 |
| NOVEL ANTI-HSA ANTIBODIES 20200325214 - 16/618864 GUNDE; Tea ; et al. | 2020-10-15 |
| ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF 20200283528 - 16/753876 GUNDE; Tea ; et al. | 2020-09-10 |
| Antibody frameworks 11,427,628 - 16/156,036 Meyer , et al. August 30, 2 | 2022-08-30 |
| Antibody frameworks 11,427,628 - 16/156,036 Meyer , et al. August 30, 2 | 2022-08-30 |
| Stable antibody variable domain framework combinations and methods of use thereof 11,421,035 - 16/648,588 Diem , et al. August 23, 2 | 2022-08-23 |
| Stable antibody variable domain framework combinations and methods of use thereof 11,421,035 - 16/648,588 Diem , et al. August 23, 2 | 2022-08-23 |
| Anti-HSA antibodies 11,365,240 - 16/618,864 Gunde , et al. June 21, 2 | 2022-06-21 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"NUMAB" 79266778 |
NUMAB 2018-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 